Stock listing
Frankfurt:XLS Xlife Sciences Ltd. Aktie
German listing (Frankfurt) of Xlife Sciences Ltd. · home listing SIX Swiss:XLS
Follow Xlife Sciences Ltd. into a list and get an email when it puts out news.
Share price · FWB:XLS
€9.10 EUR +0.15 (+1.7%)
Close on Oct 30, 2026
- Day range
- €7.60 – €9.10 EUROct 30, 2026
- Market cap
- €52.48M EURAt the close on Oct 30, 2026 · price × 5.77M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:XLS · Home | 8.80 CHF | -0.02 (-0.2%) | 3,653 | 8.94 | 9.00 | 8.80 | 8.82 | Close on Oct 30, 2026 |
| Frankfurt:XLS | €9.10 EUR | +0.15 (+1.7%) | — | €9.10 | €9.10 | €7.60 | €8.95 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:XLS
- Asset type
- Stock
- Sector
- Financials
- Industry
- Investment companies & funds
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Apr 28, 2026
Xlife Sciences AG publishes 2025 Annual Report: Strategic positioning and preparation of key capital market transactions
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 22 slides
Latest news
Decks
Investor Presentation (September 2026)
Investor deck · 22 slides · Sep 14, 2026
Investor Presentation (June 2026)
Investor deck · 20 slides · Jun 2, 2026
Xlife Sciences Ltd. on 6ix
- Sector
- Financials
- Industry
- Investment companies & funds
- News releases
- 5 in the last 12 months · 12 in all · newest Apr 28, 2026 · oldest 2025
- Decks
- 2 decks · latest Sep 14, 2026
Where Xlife Sciences Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:XLS · Home listing | SIX Swiss | Switzerland | CHF |
| Frankfurt:XLS · This page | Frankfurt | Germany | EUR |
| Turquoise:XLSZ | Turquoise | United Kingdom | CHF |
| BX Swiss:XLS | BX Swiss | Switzerland | CHF |
| Aquis:XLSZ | Aquis | United Kingdom | CHF |
| Dusseldorf:XLS | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Xlife Sciences Ltd.